| abstract |
Compositions containing protease inhibitors and methods of use and production are described. This composition contains an effective amount of a protease inhibitor in a carrier or diluent and is used to treat inflammatory and hyperproliferative mucocutaneous disorders. Preferably, the carrier or diluent is a gelling agent and the composition is a topical gel formulation comprising alpha 1-antitrypsin in an aqueous liquid or viscous gel formulation. |